Beginning with some of the earliest publications suggesting the association between bisphosphonate treatment for osteoporosis and coincident skeletal fractures, the wide range of fractured bones reported have included the metatarsals. This paper presents a survey of the medical l...
Open access
Research Article10.9734/JAMPS/2018/42283
Aims: An increasing number atypical femoral fractures (AFFs) have been reported in patients who have taken bisphosphonates (BPs) for several years. The European Medicines Agency (EMA) concluded in 2011 that these fractures were a class effect of the drugs. The United States Food...
Open access
Research Article10.9734/IJMPCR/2017/36791
Aims: From 2003, low-impact fractures have been reported in association with bisphosphonate (BP) therapy. Most have involved the proximal femur, but over 100 cases involving other anatomic locations have been published. The 2010 American Society for Bone and Mineral Research case...
Open access
Research Article10.9734/IJMPCR/2017/33170
Aims: Responding to the steadily increasing number of unusual subtrochanteric and mid-shaft femoral (ST/FS) fractures in persons treated with the bisphosphonate drugs since the index cases were described in 2003, the American Society of Bone and Mineral Research (ASBMR) convened...
Open access
Research Article10.9734/BJMMR/2017/31269
A 70 year old Caucasian female had been prescribed alendronate for osteopenia 4 years earlier. While on an overseas vacation, the day after enjoying an ocean swim, she experienced a sudden displaced fracture of her right femur while walking across a room. This fracture was treat...
Open access
Research Article10.9734/IJMPCR/2016/31352